About
TaiLai Biosciences develops liquid biopsy assays using a proprietary multi-omics platform to enable earlier cancer detection and assist diagnosis and treatment in early disease stages.
Explore TaiLai Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.